Ascendis Pharma, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $11.1M | 3,260 | 82.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.5M | 577 | 10.8% |
| Consulting Fee | $417,251 | 145 | 3.1% |
| Travel and Lodging | $293,413 | 1,100 | 2.2% |
| Food and Beverage | $239,513 | 6,664 | 1.8% |
| Education | $367.36 | 36 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| foresiGHt | $2.5M | 0 | 274 |
| New InsiGHts | $1.7M | 0 | 703 |
| enliGHten | $1.6M | 0 | 510 |
| foresiGHt extension | $1.0M | 0 | 136 |
| PaTH Forward | $863,837 | 0 | 179 |
| ApproaCH | $742,970 | 0 | 54 |
| PaTHway TRIAL | $694,652 | 1 | 107 |
| EAP of Palopegteriparatide in Patients With Hypoparathyroidism | $566,781 | 0 | 1,064 |
| SkybriGHt | $552,858 | 1 | 83 |
| SkyPASS | $540,885 | 1 | 81 |
| PaTHway | $204,267 | 0 | 54 |
| Emerald | $117,310 | 0 | 7 |
| IL Believe: A Phase 1/2, Open-label, Dose Escalation and Dose Expansion Study to Investigate the Safety and Tolerability of TransCon IL-2 / Alone or in Combination with Pembrolizumab or Standard of Care Chemotherapy in Participants Aged 18 Years or Older with Locally Advanced or Metastatic Solid Tumor Malignancies | $52,838 | 0 | 7 |
| BelieveIT-201 | $34,710 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 102
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Joseph Mctygue, Aprn-Np, APRN-NP | Family | Lincoln, NE | $13.29 | $0 |
| Dr. Kara Meinke Baehr, M.d, M.D | Endocrinology, Diabetes & Metabolism | Lincoln, NE | $13.29 | $0 |
| Dr. Prathima Jasti, M.d, M.D | Internal Medicine | Lincoln, NE | $13.29 | $0 |
| Margaret Baldwin, Pa, PA | Physician Assistant | Sandy, UT | $13.28 | $0 |
| Penne Drake, Dnp, Np, DNP, NP | Nurse Practitioner | Orlando, FL | $13.19 | $0 |
| Theresa Fynn, Md, MD | Specialist | Saint Cloud, FL | $13.16 | $0 |
| Yolanda Palmero, Rnp, RNP | Family | Saint Cloud, FL | $13.16 | $0 |
| Carolina Hewitt, Aprn, APRN | Family | Florence, SC | $13.09 | $0 |
| Mansi Kanhere, M.d, M.D | Pediatrics | Morristown, NJ | $13.08 | $0 |
| Aditi Khokhar, Mbbs, MBBS | Pediatrics | Morristown, NJ | $13.08 | $0 |
| Dr. Anna Solum, Md, MD | Internal Medicine | Burlington, NC | $13.04 | $0 |
| Dr. Thomas O'connell, Md, MD | Endocrinology, Diabetes & Metabolism | Burlington, NC | $13.04 | $0 |
| Cassandra Gonzalez-Hernandez, Pa-C, PA-C | Physician Assistant | Burlington, NC | $13.04 | $0 |
| Jaya Kothapally, M.d, M.D | Endocrinology, Diabetes & Metabolism | Willingboro, NJ | $13.04 | $0 |
| Philip George, Md, MD | Internal Medicine | Willingboro, NJ | $13.04 | $0 |
| Abby Lowe, Do, DO | Emergency Medicine | Hackensack, NJ | $13.04 | $0 |
| Ileana Tandron, Md, MD | Endocrinology, Diabetes & Metabolism | Slidell, LA | $13.00 | $0 |
| Ms. Kaleena Francois, Pa-C, PA-C | Medical | Kissimmee, FL | $12.90 | $0 |
| Hanna Fogg, D.o, D.O | Endocrinology, Diabetes & Metabolism | Tulsa, OK | $12.78 | $0 |
| Dr. Swaroopa Bartakke, Md, MD | Endocrinology, Diabetes & Metabolism | Nashville, TN | $12.78 | $0 |
| Lauren Hassan Nelson, Do, DO | Internal Medicine | Jacksonville, FL | $12.77 | $0 |
| Dr. Saka Kazeem, M.d, M.D | Endocrinology, Diabetes & Metabolism | Brooklyn, NY | $12.69 | $0 |
About Ascendis Pharma, Inc.
Ascendis Pharma, Inc. has made $13.6M in payments to 2,551 healthcare providers, recorded across 11,782 transactions in the CMS Open Payments database. In 2024, the company paid $4.2M. The top product by payment volume is SKYTROFA ($5.8M).
Payments were distributed across 82 medical specialties. The top specialty by payment amount is Pediatric Endocrinology ($996,259 to 291 doctors).
Payment categories include: Food & Beverage ($239,513), Consulting ($417,251), Research ($11.1M), Travel & Lodging ($293,413).
Ascendis Pharma, Inc. is associated with 3 products in the CMS Open Payments database.